Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-26-286494
Filing Date
2026-06-29
Accepted
2026-06-26 21:58:32
Documents
19

Document Format Files

Seq Description Document Type Size
1 424B5 d125210d424b5.htm 424B5 1009685
2 EX-FILING FEES d125210dexfilingfees.htm   iXBRL EX-FILING FEES 22656
3 GRAPHIC g125210g00k01.jpg GRAPHIC 59572
4 GRAPHIC g125210g01a26.jpg GRAPHIC 22041
5 GRAPHIC g125210g01a27.jpg GRAPHIC 22931
6 GRAPHIC g125210g01a28.jpg GRAPHIC 23242
7 GRAPHIC g125210g01a29.jpg GRAPHIC 21634
8 GRAPHIC g125210g01b26.jpg GRAPHIC 23674
9 GRAPHIC g125210g01b29.jpg GRAPHIC 25527
10 GRAPHIC g125210g03g45.jpg GRAPHIC 37971
  Complete submission text file 0001193125-26-286494.txt   1486507

Data Files

Seq Description Document Type Size
22 EXTRACTED XBRL INSTANCE DOCUMENT d125210dexfilingfees_htm.xml XML 7625
Mailing Address 1500 BROADWAY SUITE 1401 NEW YORK NY 10036
Business Address 1500 BROADWAY SUITE 1401 NEW YORK NY 10036 332-208-6102
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

EIN.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-285621 | Film No.: 261131090
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)